SCM

Soleus Capital Management Portfolio holdings

AUM $1.45B
1-Year Est. Return 18.23%
This Quarter Est. Return
1 Year Est. Return
+18.23%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$173M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
102
New
Increased
Reduced
Closed

Top Buys

1 +$66.1M
2 +$34.8M
3 +$29.9M
4
ELV icon
Elevance Health
ELV
+$27.2M
5
UNH icon
UnitedHealth
UNH
+$26.9M

Top Sells

1 +$21.7M
2 +$20.3M
3 +$18.7M
4
MRUS icon
Merus
MRUS
+$18.2M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$18M

Sector Composition

1 Healthcare 99.87%
2 Consumer Staples 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRYS icon
1
Krystal Biotech
KRYS
$5.52B
$127M 8.4%
922,958
+481,200
NVCR icon
2
NovoCure
NVCR
$1.58B
$123M 8.14%
6,904,302
+1,382,888
TGTX icon
3
TG Therapeutics
TGTX
$5.59B
$80.8M 5.35%
2,243,935
-602,768
UTHR icon
4
United Therapeutics
UTHR
$19.1B
$60.3M 3.99%
209,794
+54,400
BBNX
5
Beta Bionics
BBNX
$912M
$55.6M 3.68%
3,820,158
+424,817
GRFS icon
6
Grifois
GRFS
$6.36B
$52M 3.45%
5,756,805
-1,333,017
STAA icon
7
STAAR Surgical
STAA
$1.32B
$50.1M 3.32%
2,984,733
+421,840
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$10.3B
$49.6M 3.28%
902,304
-177,000
ORGO icon
9
Organogenesis Holdings
ORGO
$516M
$45.2M 2.99%
12,343,351
-135,000
PRAX icon
10
Praxis Precision Medicines
PRAX
$4B
$40.7M 2.69%
966,740
-173,000
CELC icon
11
Celcuity
CELC
$2.78B
$40.2M 2.66%
3,011,818
+437,696
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$62.1B
$34.8M 2.31%
+106,750
TERN icon
13
Terns Pharmaceuticals
TERN
$711M
$30.5M 2.02%
8,167,100
URGN icon
14
UroGen Pharma
URGN
$839M
$29.9M 1.98%
+2,185,000
NRIX icon
15
Nurix Therapeutics
NRIX
$801M
$27.6M 1.83%
2,422,833
ELV icon
16
Elevance Health
ELV
$78.8B
$27.2M 1.8%
+70,000
UNH icon
17
UnitedHealth
UNH
$331B
$26.9M 1.78%
+86,250
NPCE icon
18
Neuropace
NPCE
$357M
$25.8M 1.71%
2,312,957
-295,211
ARGX icon
19
argenx
ARGX
$51.4B
$23.6M 1.57%
42,876
+13,936
SRDX icon
20
Surmodics
SRDX
$402M
$23.4M 1.55%
789,060
GERN icon
21
Geron
GERN
$810M
$22.8M 1.51%
16,140,000
+13,740,000
CDTX icon
22
Cidara Therapeutics
CDTX
$2.62B
$22.5M 1.49%
+462,811
EOLS icon
23
Evolus
EOLS
$439M
$19.5M 1.29%
2,119,000
+1,039,842
HUM icon
24
Humana
HUM
$35.5B
$19.5M 1.29%
+79,600
VCYT icon
25
Veracyte
VCYT
$2.84B
$19.3M 1.28%
+715,439